COMPANY OVERVIEW

Tetra Discovery Partners is a pharmaceutical drug development company development medicines for Alzheimer's Disease, Traumatic Brain Injury, and schizophrenia. The drugs in their pipeline offer a new mechanism of acition focused on PDE4B and PDE4D.

---

LOCATION

---

THERAPEUTIC AREAS

Neurological Disorders

---

WEBSITE

https://tetradiscovery.com

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Aug 5, 2019

Tetra Discovery Partners Announces Name Change to Tetra Therapeutics

May 1, 2019

Tetra Discovery Partners Initiates Phase 2 Clinical Trial of BPN14770 in Patients with Early Alzheimer’s Disease

Dec 18, 2018

Tetra Discovery Partners and Shionogi and Co., Ltd. Collaborate on BPN14770 Development and Commercialization

Oct 11, 2018

Intellectual Property Protection for Tetra Discovery Partners’ BPN14770 Boosted with Issuance of New U.S. Patent

Jul 10, 2018

Tetra Discovery Partners Initiates Phase 2 Trial of BPN14770 in Fragile X Syndrome

For More Press Releases

---